CWM
IRMD icon

CarsonAllaria Wealth Management’s iRadimed IRMD Stock Holding History

CarsonAllaria Wealth Management’s Portfolio IRMD Stock Details IRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-277
Closed -$13.3K – 382
2023
Q2 		$13.3K Hold
277
– – 0.01% 200
2023
Q1 		$10.9K Hold
277
– – 0.01% 208
2022
Q4 		$8K Sell
277
-1
-0.4% -$29 0.01% 208
2022
Q3 		$8K Buy
278
+1
+0.4% +$35 0.01% 204
2022
Q2 		$9K Sell
277
-1
-0.4% -$36 0.01% 200
2022
Q1 		$12K Buy
278
+3
+1% +$139 0.01% 186
2021
Q4 		$13K Buy
+275
New +$11.1K 0.01% 194

Other funds holding IRMD

NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCMC
RK Capital Management (Colorado) Denver, Colorado $324K AUM 47.52% 1-Year Est. Return
BCM
Bares Capital Management Austin, Texas $1.08B AUM 38.13% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

CarsonAllaria Wealth Management's IRMD Position: Q3 2023 in Review

CarsonAllaria Wealth Management sold out of iRadimed (IRMD) in Q3 2023, closing a stake of 277 shares — an estimated $13.3K sold.

CarsonAllaria Wealth Management first reported a position in IRMD in Q4 2021 and held it in 7 quarters. The position peaked at $13.3K in Q2 2023. 113 funds tracked by Wall St. Rank hold IRMD as of Q3 2023.

  • CarsonAllaria Wealth Management reported no remaining iRadimed position as of Q3 2023 after selling out during the quarter.
  • CarsonAllaria Wealth Management sold 277 iRadimed shares in Q3 2023, an estimated $13.3K.
  • CarsonAllaria Wealth Management first reported a position in iRadimed in Q4 2021 and held it in 7 quarters.
  • CarsonAllaria Wealth Management's iRadimed position peaked at $13.3K in Q2 2023.
  • 113 funds tracked by Wall St. Rank held iRadimed as of Q3 2023.

Based on CarsonAllaria Wealth Management's 13F filing for Q3 2023, filed 9 Nov 2023.